HERRESOLVE Trademark

Trademark Overview


On Friday, August 9, 2024, a trademark application was filed for HERRESOLVE with the United States Patent and Trademark Office. The USPTO has given the HERRESOLVE trademark a serial number of 98691064. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, October 1, 2025. This trademark is owned by Heranova Biosciences Inc. The HERRESOLVE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information in the field of gynecology; medical information services in the gynecological field; medical diagnostic services for gynecological diseases; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely diagnostic services for detecting endometriosis by identifying and analyzing biomarkers for diagnostic or treatment purposes.

Medical diagnostic assay reagents for testing for the presence of biomarkers in blood for diagnosing gynecological diseases, namely endometriosis.
herresolve

General Information


Serial Number98691064
Word MarkHERRESOLVE
Filing DateFriday, August 9, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, October 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding medical information in the field of gynecology; medical information services in the gynecological field; medical diagnostic services for gynecological diseases; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely diagnostic services for detecting endometriosis by identifying and analyzing biomarkers for diagnostic or treatment purposes.
Goods and ServicesMedical diagnostic assay reagents for testing for the presence of biomarkers in blood for diagnosing gynecological diseases, namely endometriosis.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 9, 2024
Primary Code005
First Use Anywhere DateMonday, December 8, 2025
First Use In Commerce DateMonday, December 8, 2025

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 9, 2024
Primary Code044
First Use Anywhere DateMonday, December 8, 2025
First Use In Commerce DateMonday, December 8, 2025

Trademark Owner History


Party NameHERANOVA LIFESCIENCES INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressOrlando, FL 32822
US

Party NameHeranova Biosciences Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, NJ 01803
US

Trademark Events


Event DateEvent Description
Friday, August 9, 2024NEW APPLICATION ENTERED
Monday, February 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 25, 2025ASSIGNED TO EXAMINER
Tuesday, March 4, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 4, 2025NON-FINAL ACTION E-MAILED
Tuesday, March 4, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 16, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 4, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 4, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, September 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 1, 2025SUSPENSION LETTER WRITTEN
Wednesday, October 1, 2025LETTER OF SUSPENSION E-MAILED
Wednesday, October 1, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 2, 2026TEAS AMENDMENT OF USE RECEIVED
Monday, March 2, 2026USE AMENDMENT FILED
Monday, March 2, 2026AMENDMENT TO USE PROCESSING COMPLETE